We are testing a new beta website for gov.scot go to new site

Hepatitis C Action Plan for Scotland - Phase I: September 2006 - August 2008

Listen

Section 7 Summary of actions

7.1 This section summarises the actions presented in the previous sections, under the agencies / organisations responsible for carrying out the action.

The Scottish Executive

  • By Oct 2006: The Scottish Executive Health Department will provide two-year funding to Health Protection Scotland and the Viral Hepatitis Group to support the continued development of the national clinical database on Hepatitis C, which records details of all individuals who attend a specialist clinic for Hepatitis C. Reports of this data will be published annually in The State of the Hepatitis C Epidemic in Scotland. [Section 4, action 2 and Section 6, action 1]
  • By Oct 2006: The Scottish Executive will commission qualitative research with professionals and with individuals recently diagnosed with Hepatitis to explore knowledge and attitudes towards Hepatitis C among these groups. [Section 5, action 1]
  • By Dec 2006: The Scottish Executive will ask NHS boards to consider whether they have the full range of interventions in place to reduce re-using and sharing of needles, syringes, and injecting paraphernalia and to promote safer injecting. These interventions should include: more outreach and mobile needle exchange services; distributing a wide range of paraphernalia (in addition to needles and syringes) in needle exchanges; and labelling or colour-coding of injecting equipment to help drug users identify their own. [Section 2, action 2]
  • By Dec 2006: Scottish Ministers will publish national quality standards for substance misuse services. [Section 2, action 3]
  • By Mar 2007: The Scottish Executive will consider the recommendations of the National Needle Exchange Survey published in July 2006. [Section 2, action 4]
  • By Apr 2007: The Scottish Executive Substance Misuse Research Team will publish the findings of research on the outcomes and risks associated with the use of injecting paraphernalia such as filters, cookers and tourniquets. [Section 2, action 5]
  • By Apr 2007: The Scottish Executive will carry out a synthesis of existing research on the effectiveness of needle exchange services in reducing the transmission of blood-borne viruses (and Hepatitis C in particular), to highlight any evidence of good practice. [Section 2, action 6]
  • By Apr 2007: The Scottish Executive will consider how to develop a module for training non-pharmacy needle exchange workers in Scotland. [Section 5, action 6]
  • By Jun 2007: The Scottish Executive will publish a review of the nature and impact of HIV and HCV public awareness-raising campaigns in other countries. [Section 5, action 7]
  • By Jul 2007: The Scottish Executive Health Department will consider how to develop a training strategy for substance misuse services in Scotland. [Section 5, action 8]
  • By Oct 2007: The Scottish Executive Health Department will publish the findings of an in-depth needs assessment undertaken in relation to Hepatitis C testing, treatment care and support services in Scotland. This work to commence in Oct 2006. [Section 3, action 4 and Section 4, action 5]
  • By Feb 2009: The Scottish Executive will publish its Action Plan for Phase II, the period beyond September 2008. [Section 1, action 10]

Health Protection Scotland

  • By Oct 2006: Health Protection Scotland will establish and chair a Hepatitis C Action Plan Co-ordinating Group ( APCG) representing the range of individuals and organisations that have a stake in this area. [Section 1, action 2]
  • Annually in Feb, starting Feb 2007: Health Protection Scotland will produce and publish a formal Hepatitis C Annual Report, The State of the Hepatitis C Epidemic in Scotland. [Section 1, action 5]
  • By Oct 2007: Health Protection Scotland will complete a two-year study to determine the cost-effectiveness of different screening approaches for Hepatitis C. An interim report of this work will be made available to the Scottish Executive by October 2006. [Section 3, action 3]
  • By Oct 2007: Health Protection Scotland will complete a two-year modelling study to estimate the cost of the current and future burden of Hepatitis C infection on the NHS. An interim report of this work will be produced by Oct 2006. [Section 4, action 6]
  • By Dec 2007: Health Protection Scotland will publish the results of a census of Hepatitis C prevalence among injecting drug users attending needle exchange services across Scotland. [Section 6, action 3]

Action Plan Co-ordinating Group

  • By Oct 2006: The APCG will form working groups on: (1) prevention; (2) testing, treatment, care and support; and (3) education, training and awareness-raising. [Section 1, action 3]
  • By Jun 2007: The APCG will draft and agree with local HCV Executive Leads and the Scottish Executive Health Department a short set of national outcome indicators for measuring progress in relation to Hepatitis C prevention, testing, treatment, care and support and training and education. [Section 1, action 7]
  • By Jan 2008: The APCG will assist the Scottish Executive in putting together proposals for funding to support improvements in the quality and accessibility of Hepatitis C-related services beyond August 2008. [Section 1, action 9]

Action Plan working groups

  • By Dec 2007: Action Plan Working Groups will submit proposals to the Action Plan Co-ordinating Group for future action on Hepatitis C to be undertaken in Scotland beyond August 2008. [Section 1, action 8]

NHS Health Scotland

  • By Oct 2006:NHS Health Scotland will conduct a review of existing communications materials for Hepatitis C. [Section 5, action 2]
  • By Dec 2006:NHS Health Scotland will develop and distribute a range of information and educational materials and resources for professionals about Hepatitis C, consulting with key stakeholder groups as appropriate. [Section 5, action 3]
  • By Sep 2007:NHS Health Scotland will ascertain the nature of current teaching on Hepatitis C in Scottish secondary schools and will review the need for guidance and resources for schools. The findings will be reported to the Scottish Executive and the Action Plan Co-ordinating Group. [Section 5, action 9]
  • By Jun 2008:NHS Health Scotland will develop materials and resources that can be used to support individuals who have been received a positive diagnosis of Hepatitis C. These will be distributed to all relevant services throughout Scotland - in particular general practices, needle exchange and harm reduction services, and prisons. [Section 5, action 10]

NHS Education Scotland

  • By Oct 2006:NHS Education Scotland, working together with the UK Hepatitis C Resource Centre, will publish a directory of Hepatitis C-related services in Scotland. This information will feed into an in-depth needs assessment of Hepatitis C testing, treatment, care and support services. [Section 4, action 3]
  • By Feb 2007:NHS Education Scotland, working together with the UK Hepatitis C Resource Centre will ascertain existing training and educational provision on Hepatitis C for NHS staff, identify gaps in existing provision and make recommendations for addressing the gaps. [Section 5, action 4]

Information Services Division ( ISD)

  • By Dec 2007 and annually: The Information Services Division ( ISD) will publish statistics on the number of individuals entering treatment for problem drug use who have been tested for Hepatitis C. This data will be presented by NHS Board. [Section 3, action 5 and Section 6, action 2]

NHS boards

  • From Sept 2006 - Aug 2008:NHS boards, together with community health partnerships, and drug and alcohol action teams, should consider whether they can use the funding allocated to them over the next two years to improve local Hepatitis C prevention services (in particular, needle exchange). They should also consider whether it is necessary to improve data collection systems, for the purpose of better informing local planning activities. [Section 2, action 1]
  • From Sept 2006 - Aug 2008:NHS Boards should consider what further work they can do, using the funding allocated over the two years of this action plan, to improve the accessibility of testing services in their area, and to identify and offer Hepatitis C testing to those who are at risk. [Section 3, action 1]
  • From Sept 2006 - Aug 2008:NHS boards and community health partnerships will consider how they can use the funding allocated to them in the two years of this Action Plan to develop or improve local community-based treatment, care and support services for people who have been diagnosed with Hepatitis C. [Section 4, action 1]
  • By Oct 2006:NHS Boards (including special Boards) will identify an HCV Executive Lead who will take responsibility for co-ordinating, planning and overseeing activity on Hepatitis C at an NHS board level. This individual will report bi-annually to the APCG on action and progress in their area. [Section 1, action 1]
  • By Dec 2006:NHS boards will submit to the Scottish Executive their proposals for spending the Phase I Hepatitis C funding available to them in 2007/08. [Section 1, action 4]
  • By Mar 2007:NHS boards will report to the Scottish Executive on their spending of the Phase I Hepatitis C funding they received in 2006/07. [Section 1, action 6]

Drug and alcohol action teams

  • Between Sept 2006 - Aug 2008: Drug and alcohol action teams, together with NHS boards and community health partnerships, should consider whether they can use the funding allocated to them over the next two years to improve local Hepatitis C prevention services (in particular, needle exchange). They should also consider whether it is necessary to improve data collection systems, for the purpose of better informing local planning activities. [Section 2, action 1]

Community Health Partnerships

  • Between Sept 2006 - Aug 2008: Community health partnerships, together with NHS boards and drug and alcohol action teams, should consider whether they can use the funding allocated to them over the next two years to improve local Hepatitis C prevention services (in particular, needle exchange). They should also consider whether it is necessary to improve data collection systems, for the purpose of better informing local planning activities. [Section 2, action 1]
  • From Sept 2006 - Aug 2008: Community health partnerships and NHS boards will consider how they can use the funding allocated to them in the two years of this Action Plan to develop or improve local community-based treatment, care and support services for people who have been diagnosed with Hepatitis C. [Section 4, action 1]

Scottish Prison Service

  • By Apr 2007: The Scottish Prison Service will pilot in-prison needle exchange in HMP Aberdeen. A report of this pilot will be available in 2009. [Section 2, action 7]
  • By Apr 2007: The Scottish Prison Service will provide access to training on Hepatitis C to all prison staff as part of a larger training programme on harm reduction. Staff in HMP Aberdeen will be given special training on safe injecting techniques as part of a pilot needle exchange scheme in that prison. [Section 5, action 5]
  • By Sep 2007: Following publication of the SIGN Guideline on Hepatitis C (expected by December 2006), the Scottish Prison Service will develop a blood-borne virus strategy for the care of prisoners. [Section 3, action 2]
  • By May 2008: The Scottish Prison Service will provide injecting paraphernalia to all prisoners with an identified need, upon their release from prison. [Section 2, action 8]

Scottish Intercollegiate Guidelines Network ( SIGN)

  • By Dec 2006:SIGN will publish their Guideline on Hepatitis C. [Section 4, action 4]

Managed Care Networks

  • By Mar 2007 and annually: The Managed Care Networks in Greater Glasgow and Clyde and Tayside will report annually to the Action Plan Co-ordinating Group on developments in their respective areas. [Section 4, action 7]